ZIOP - ZIOPHARM Oncology, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

ZIOP is currently covered by 1 analysts with average potential upside of $1.79 (30.37%) backed by 11 price targets and 14 ratings. Documented since 26-Mar-2013. Analyst's average stock valuation to be materialised ratio is 9.52% with an average time for price targets to be met of 543.67 days.

Most recent stock forecast was given by DAVID NOVAK from RAYMOND JAMES on 10-Aug-2021.

Highest price target for ZIOP is 2, Lowest price target is 2, average price target is 2.

Best performing analysts who are covering ZIOP - ZIOPHARM Oncology, Inc:

Jim Birchenough David Novak Chris Howerton

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

3

$2.17 (261.45%)

1 years 7 months 13 days ago

0/2 (0%)

$0.74 (31.70%)

Buy

5

$4.17 (502.41%)

2 years 11 days ago

0/1 (0%)

$0.61 (13.90%)

Hold

6 years 7 months 13 days ago

2/7 (28.57%)

$4.02 (45.52%)

1631

Show more analysts